NYSE:EVH - Evolent Health Stock Price, News & Analysis

Evolent Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVH."

Evolent Health Inc (NYSE:EVH) released its quarterly earnings data on Tuesday, August, 6th. The technology company reported ($0.26) EPS for the quarter, topping analysts' consensus estimates of ($0.29) by $0.03. The technology company had revenue of $192 million for the quarter, compared to the consensus estimate of $192.51 million. Evolent Health had a negative net margin of 14.67% and a negative return on equity of 6.47%. The firm's revenue was up 33.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.03) earnings per share. View Evolent Health's Earnings History.

Evolent Health is scheduled to release their next quarterly earnings announcement on Tuesday, November 5th 2019. View Earnings Estimates for Evolent Health.

8 brokers have issued 1-year price targets for Evolent Health's shares. Their forecasts range from $10.00 to $35.00. On average, they anticipate Evolent Health's stock price to reach $20.9375 in the next year. This suggests a possible upside of 162.0% from the stock's current price. View Analyst Price Targets for Evolent Health.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Evolent Health in the last year. There are currently 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Evolent Health.

Media headlines about EVH stock have been trending negative recently, InfoTrie reports. InfoTrie ranks the sentiment of media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Evolent Health earned a news sentiment score of -2.9 on InfoTrie's scale. They also assigned news articles about the technology company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the near future. View News Stories for Evolent Health.

Some companies that are related to Evolent Health include R1 RCM (RCM), Franklin Covey (FC), Jupai (JP), PHI Group (PHIL) and Rainmaker Systems (VCTL).

Based on aggregate information from My MarketBeat watchlists, some companies that other Evolent Health investors own include CA (CA), BlackRock (BLK), Universal Insurance (UVE), Endologix (ELGX), Chipotle Mexican Grill (CMG), Advanced Micro Devices (AMD), Aegean Marine Petroleum Network (ANW), Micron Technology (MU), Mobileye (MBBYF) and NVIDIA (NVDA).

(EVH) raised $150 million in an IPO on Friday, June 5th 2015. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs acted as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers.

Evolent Health's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (7.95%), BlackRock Inc. (6.00%), Riverbridge Partners LLC (4.12%), Eagle Asset Management Inc. (2.24%), Cortina Asset Management LLC (2.03%) and Marshall Wace LLP (1.95%). Company insiders that own Evolent Health stock include Cheryl Scott, Doug S Aron, Frank J Williams, Jonathan Weinberg, Kenneth A Samet, Lydia Stone, Michael D'amato, Seth Blackley, Thomas Peterson III and Unitedhealth Group Inc. View Institutional Ownership Trends for Evolent Health.

EVH stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Waddell & Reed Financial Inc., D. E. Shaw & Co. Inc., Eagle Asset Management Inc., Invesco Ltd., Riverbridge Partners LLC, First Trust Advisors LP and Cubist Systematic Strategies LLC. View Insider Buying and Selling for Evolent Health.

EVH stock was purchased by a variety of institutional investors in the last quarter, including Marshall Wace LLP, Vanguard Group Inc., Canada Pension Plan Investment Board, Prudential Financial Inc., Voce Capital Management LLC, Nuveen Asset Management LLC, Marshall Wace North America L.P. and Handelsbanken Fonder AB. Company insiders that have bought Evolent Health stock in the last two years include Doug S Aron, Kenneth A Samet and Michael D'amato. View Insider Buying and Selling for Evolent Health.

Shares of EVH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of EVH stock can currently be purchased for approximately $7.99.

Evolent Health has a market capitalization of $675.31 million and generates $627.06 million in revenue each year. The technology company earns $-52,660,000.00 in net income (profit) each year or ($0.35) on an earnings per share basis. Evolent Health employs 3,800 workers across the globe.View Additional Information About Evolent Health.

The official website for Evolent Health is http://www.evolenthealth.com/.

Evolent Health's mailing address is 800 NORTH GLEBE RD SUITE 500, ARLINGTON VA, 22203. The technology company can be reached via phone at 571-389-6000.